 |
> publications
> pharmacy practice program
> pharmaceutical sciences program
|
|
|
|
Department of Pharmacy Practice Faculty Publications
Within the Past 2 Years
Dr. Nicole Albanese |
Monte SV, Paolini NM, Slazak EM, Schentag JJ, Paladino JA, Albanese NM; Costs of treating lower respiratory tract infections. Am J Manag Care; 2008 Apr; 14(4). Journal Article
Paolini NM, Coe H; Systemic lupus erythematosus ; 2008 Jan.
|
Dr. Edward Bednarczyk |
Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K; A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone). J Clin Pharmacol; 2007 Dec; 47(12). Journal Article
Kassab MY, Majid A, Bakhtar O, Farooq MU, Patel K, Bednarczyk EM; Transcranial Doppler measurements in migraine and nitroglycerin headache. J Headache Pain; 2007 Oct; 8(5). Journal Article
Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K; A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone). J Clin Pharmacol; 2007 Oct. Journal Article
|
Dr. J Bell |
Krzyzanski W, Bell J; Modelling the geometric features and investigating electrical properties of dendrites in a fish thalamic neuron. Math Med Biol; 2007 Sep; 24(3). Journal Article
|
Mr. Terry Bellnier |
No Recent Publications
|
Dr. Angela Bosinski |
No Recent Publications
|
Dr. Peter Brody |
No Recent Publications
|
Jack Brown |
No Recent Publications
|
Dr. Linda Catanzaro |
McCabe SM, Ma Q, Slish JC, Catanzaro LM, Sheth N, DiCenzo R, Morse GD; Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment. Clin Pharmacokinet; 2008 Jan; 47(3). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
|
Alice Ceacareanu |
No Recent Publications
|
Holly Coe |
Paolini NM, Coe H; Systemic lupus erythematosus ; 2008 Jan.
|
Dr. Mary Anne Dannenhoffer |
No Recent Publications
|
Dr. Tammie Demler |
Bitter R, Demler TL, Opler L, Demler T; Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review. J Psychiatr Pract; 2008 Sep; 14(5). Journal Article
|
Fred Doloresco |
No Recent Publications
|
Mr. Karl Fiebelkorn |
No Recent Publications
|
Dr. Alan Forrest |
Bulitta JB, Ly NS, Yang JC, Forrest A, Jusko WJ, Tsuji BT; Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime Against Pseudomonas aeruginosa. Antimicrob Agents Chemother; 2008 Oct. Journal Article
Bhavnani SM, Forrest A, Hammel JP, Drusano GL, Rubino CM, Ambrose PG; Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia. Diagn Microbiol Infect Dis; 2008 Sep; 62(1). Journal Article
Tsuji BT, Yang JC, Forrest A, Kelchlin PA, Smith PF; In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus. J Antimicrob Chemother; 2008 Jul; 62(1). Journal Article
Nelsen JL, Haas CE, Habtemariam B, Kaufman DC, Partridge A, Welle S, Forrest A; A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients. J Intensive Care Med; 2008 May; 23(3). Journal Article
Moise PA, Castro RS, Sul C, Forrest A, Sakoulas G; Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection. Ann Pharmacother; 2008 Apr; 42(4). Letter
Tsuji BT, von Eiff C, Kelchlin PA, Forrest A, Smith PF; Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob Agents Chemother; 2008 Apr; 52(4). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2008 Mar; 29(2). Journal Article
Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V; Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. J Clin Pharmacol; 2008 Mar; 48(3). Clinical Trial
Forrest A, Huizinga JD, Wang XY, Liu LW, Parsons M; Increase in stretch-induced rhythmic motor activity in the diabetic rat colon is associated with loss of ICC of the submuscular plexus. Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1). Journal Article
Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A, Sakoulas G; Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother; 2008 Jan; 61(1). Clinical Trial, Phase III
Ambrose PG, Forrest A, Craig WA, Rubino CM, Bhavnani SM, Drusano GL, Heine HS; Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model. Antimicrob Agents Chemother; 2007 Dec; 51(12). Journal Article
Yang JC, Tsuji BT, Forrest A; Optimizing use of quinolones in the critically ill. Semin Respir Crit Care Med; 2007 Dec; 28(6). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Smith PF, Ogundele A, Forrest A, Wilton J, Salzwedel K, Doto J, Allaway GP, Martin DE; Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection. Antimicrob Agents Chemother; 2007 Oct; 51(10). Clinical Trial, Phase I
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, Gandhi PJ; Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm; 2007 Sep; 13(7). Clinical Trial
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
|
Dr. Francis Gengo |
Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V; Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. J Clin Pharmacol; 2008 Mar; 48(3). Clinical Trial
Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V; Effects of Ibuprofen on the Magnitude and Duration of Aspirin‘s Inhibition of Platelet Aggregation: Clinical Consequences in Stroke Prophylaxis. J Clin Pharmacol; 2008 Jan; 48(1). Journal Article
Hong Y, Gengo FM, Rainka MM, Bates VE, Mager DE; Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects. Clin Pharmacokinet; 2008 Jan; 47(2). Journal Article
|
Dr. Patty Havard |
No Recent Publications
|
Richard Kraft |
No Recent Publications
|
Dr. Qing Ma |
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2008 Mar; 29(2). Journal Article
McCabe SM, Ma Q, Slish JC, Catanzaro LM, Sheth N, DiCenzo R, Morse GD; Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment. Clin Pharmacokinet; 2008 Jan; 47(3). Journal Article
McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM; Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend; 2007 Dec; 91(2-3). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
|
Dr. Charles Maponga |
No Recent Publications
|
Scott Monte |
Monte SV, Paolini NM, Slazak EM, Schentag JJ, Paladino JA, Albanese NM; Costs of treating lower respiratory tract infections. Am J Manag Care; 2008 Apr; 14(4). Journal Article
|
Dr. Gene Morse |
Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV; Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis; 2008 Aug; 47(3). Clinical Trial
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2008 Mar; 29(2). Journal Article
Demeter LM, Mukherjee AL, DiFrancesco R, Jiang H, DiCenzo R, Bastow B, Rinehart AR, Morse GD, Albrecht M; The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients. HIV Clin Trials; 2008 Jan; 9(1). Clinical Trial, Phase II
McCabe SM, Ma Q, Slish JC, Catanzaro LM, Sheth N, DiCenzo R, Morse GD; Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment. Clin Pharmacokinet; 2008 Jan; 47(3). Journal Article
McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM; Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend; 2007 Dec; 91(2-3). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
DiFrancesco R, DiCenzo R, Vicente G, Donnelly J, Martin TM, Colon LA, Schifito G, Morse GD; Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal; 2007 Sep; 44(5). Journal Article
|
Nicholas Norgard |
No Recent Publications
|
Dr. Joseph Paladino |
Monte SV, Prescott WA, Johnson KK, Kuhman L, Paladino JA; Safety of ceftriaxone sodium at extremes of age. Expert Opin Drug Saf; 2008 Sep; 7(5). Journal Article
Paladino JA, Sunderlin JL, Singer ME, Adelman MH, Schentag JJ; Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance. Am J Health Syst Pharm; 2008 Jun; 65(12). Journal Article
Paladino JA, Gilliland-Johnson KK, Adelman MH, Cohn SM; Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections. Surg Infect (Larchmt); 2008 Jun; 9(3). Journal Article
McKinnon PS, Paladino JA, Schentag JJ; Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents; 2008 Apr; 31(4). Journal Article
Monte SV, Paolini NM, Slazak EM, Schentag JJ, Paladino JA, Albanese NM; Costs of treating lower respiratory tract infections. Am J Manag Care; 2008 Apr; 14(4). Journal Article
Paladino JA, Schentag JJ; The economics of Clostridium difficile-associated disease for providers and payers. Clin Infect Dis; 2008 Feb; 46(4). Comment
Carswell CI, Paladino JA; Meandering down the road to transparency. Pharmacoeconomics; 2008 Jan; 26(3). Comment
Iannini PB, Paladino JA, Lavin B, Singer ME, Schentag JJ; A case series of macrolide treatment failures in community acquired pneumonia. J Chemother; 2007 Oct; 19(5). Journal Article
Schentag JJ, Klugman KP, Yu VL, Adelman MH, Wilton GJ, Chiou CC, Patel M, Lavin B, Paladino JA; Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Int J Antimicrob Agents; 2007 Sep; 30(3). Journal Article
Paladino JA, Sunderlin JL, Adelman MH, Singer ME, Schentag JJ; Observations on vancomycin use in U.S. hospitals. Am J Health Syst Pharm; 2007 Aug; 64(15). Journal Article
|
Dr. Mary Pasko |
Mergenhagen KA, Pasko MT, Pasko M; Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis. Ann Pharmacother; 2007 Sep; 41(9). Case Reports
|
Dr. William Prescott |
Monte SV, Prescott WA, Johnson KK, Kuhman L, Paladino JA; Safety of ceftriaxone sodium at extremes of age. Expert Opin Drug Saf; 2008 Sep; 7(5). Journal Article
|
Mr. Alfred Reiman |
No Recent Publications
|
Joshua Sawyer |
No Recent Publications
|
Dr. Erin Slazak |
Monte SV, Paolini NM, Slazak EM, Schentag JJ, Paladino JA, Albanese NM; Costs of treating lower respiratory tract infections. Am J Manag Care; 2008 Apr; 14(4). Journal Article
|
Dr. Kathleen Tornatore |
Nainani N, Singh N, Shanahan T, Damodar A, Parimoo N, Ummadi S, Qazi Y, Murray BM, Tornatore KM, Ciccirella JC, Blessios GA, Venuto RC; Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection. Transpl Immunol; 2008 Nov. Journal Article
Difrancesco R, Frerichs V, Donnelly J, Hagler C, Hochreiter J, Tornatore KM; Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1). Journal Article
|
Dr. Brian Tsuji |
Bulitta JB, Ly NS, Yang JC, Forrest A, Jusko WJ, Tsuji BT; Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime Against Pseudomonas aeruginosa. Antimicrob Agents Chemother; 2008 Oct. Journal Article
Tsuji BT, Yang JC, Forrest A, Kelchlin PA, Smith PF; In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus. J Antimicrob Chemother; 2008 Jul; 62(1). Journal Article
Tsuji BT, von Eiff C, Kelchlin PA, Forrest A, Smith PF; Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob Agents Chemother; 2008 Apr; 52(4). Journal Article
Tsuji BT, Leonard SN, Rhomberg PR, Jones RN, Rybak MJ; Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serum. Diagn Microbiol Infect Dis; 2008 Apr; 60(4). Journal Article
Yang JC, Tsuji BT, Forrest A; Optimizing use of quinolones in the critically ill. Semin Respir Crit Care Med; 2007 Dec; 28(6). Journal Article
Narita M, Tsuji BT, Yu VL; Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy; 2007 Aug; 27(8). Case Reports
|
Dr. Robert Wahler |
No Recent Publications
|
Dr. Mark Wrobel |
No Recent Publications
|
Dr. Gina Zurick |
Pretorius RW, Zurick GM, Zurick G; A systematic approach to identifying drug-seeking patients. Fam Pract Manag; 2008 Apr; 15(4). Journal Article
|
|
|
Faces & Stories |
 |
|
|
|
|
We interviewed students, faculty, and alumni—here's what they had to say.
» Learn more
|
|
|
